Letter to the Editor from Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for 131I Administration”
Open Access
- 25 January 2023
- journal article
- letter
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 7 (3), bvad004
- https://doi.org/10.1210/jendso/bvad004
Abstract
Wouter T Zandee, Thera P Links; Letter to the Editor from Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of PreparatThis publication has 4 references indexed in Scilit:
- Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for 131I AdministrationJournal of the Endocrine Society, 2022
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancerEmergencias, 2010
- A Comparison of Short-Term Changes in Health-Related Quality of Life in Thyroid Carcinoma Patients Undergoing Diagnostic Evaluation with Recombinant Human Thyrotropin Compared with Thyroid Hormone WithdrawalJournal of Clinical Endocrinology & Metabolism, 2006